Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: Evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus

References

• Kammer GM, Perl A, Richardson BC, Tsokos GC. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum. 2002; 46:1139–1154.
   PubMed Web of Science ®Google Scholar
• Hahn BH, Bagby KK, Osterland CK. Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med. 1973; 55:25–31.
   PubMed Web of Science ®Google Scholar
• Horwitz DA. Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972; 15:353–359.
   PubMed Web of Science ®Google Scholar
• Gottlieb AB, Lahita RG, Chiorazzi N, Kunkel HG. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest. 1979; 63:885–892.
   PubMed Web of Science ®Google Scholar
• Tsokos GC, Balow JE. Cytotoxic responses to alloantigen in systemic lupus erythematosus. J Clin Immunol. 1981; 1:208–216.
   PubMedGoogle Scholar
• Perl A, Gonzalez-Cabello R, Lang I, Gergely P. Depressed natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells in patients with systemic lupus erythematosus. Immunol Commun. 1982; 11:431–440.
   PubMed Web of Science ®Google Scholar
• Perl A, Gonzalez-Cabello R, Gergely P. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus. J Clin Lab Immunol. 1984; 15:95–100.
   PubMedGoogle Scholar
• Tsokos GC. Overview of cellular immune function in SLE. In: Lahita RG, editor. Systemic lupus erythematosus. New York: Churchill Livingstone; 1992. 15–50.
   Google Scholar
• Tsokos GC, Smith PL, Christian CB, Lipnick RN, Balow JE, Djeu JY. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1985; 34:379–386.
   PubMedGoogle Scholar
• Alcocer-Varela J, Alarcon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest. 1982; 69:1388–1392.
   PubMed Web of Science ®Google Scholar
• Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus [SLE]. J Immunol. 1983; 130:2651–2655.
   PubMed Web of Science ®Google Scholar
• Draeger AM, Swaak AJ, van den Brink HG, Aarden LA. T cell function in systemic lupus erythematosus: Normal production of and responsiveness to interleukin 2. Clin Exp Immunol. 1986; 64:80–87.
   PubMed Web of Science ®Google Scholar
• Handwerger BS, Rus V, da Silva L, Via CS. The role of cytokines in the immunopathogenesis of lupus. Springer Semin Immunopathol. 1994; 16:153–180.
   PubMed Web of Science ®Google Scholar
• Altman A, Theofilopoulos AN, Weiner R, Katz DH, Dixon FJ. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med. 1981; 154:791–808.
   PubMed Web of Science ®Google Scholar
• Dauphinee MJ, Kipper SB, Wofsy D, Talal N. Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol. 1981; 127:2483–2487.
   PubMed Web of Science ®Google Scholar
• Wofsy D, Murphy ED, Roths JB, Dauphinee MJ, Kipper SB, Talal N. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J Exp Med. 1981; 154:1671–1680.
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349:1526–1533.
   PubMed Web of Science ®Google Scholar
• Gleichmann E, Gleichmann H. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J Invest Dermatol. 1985; 85:115s–120s.
   PubMed Web of Science ®Google Scholar
• Gleichmann E, Van Elven EH, Van der Veen JP. A systemic lupus erythematosus [SLE]-like disease in mice induced by abnormal T–B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol. 1982; 12:152–159.
   PubMed Web of Science ®Google Scholar
• Eisenberg R. The chronic graft-versus-host model of systemic autoimmunity. Curr Dir Autoimmun. 2003; 6:228–244.
   PubMedGoogle Scholar
• Grader-Beck T, Casciola-Rosen L, Lang TJ, Puliaev R, Rosen A, Via CS. Apoptotic splenocytes drive the autoimmune response to poly[ADP-ribose] polymerase 1 in a murine model of lupus. J Immunol. 2007; 178:95–102.
   PubMed Web of Science ®Google Scholar
• Morris SC, Cheek RL, Cohen PL, Eisenberg RA. Autoantibodies in chronic graft versus host result from cognate T–B interactions. J Exp Med. 1990; 171:503–517.
   PubMed Web of Science ®Google Scholar
• Niculescu F, Niculescu T, Nguyen P, Puliaev R, Papadimitriou JC, Gaspari A, Rus H, Via CS. Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp Mol Pathol. 2005; 79:136–145.
   PubMed Web of Science ®Google Scholar
• Via CS, Sharrow SO, Shearer GM. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol. 1987; 139:1840–1849.
   PubMed Web of Science ®Google Scholar
• Puliaev R, Puliaeva I, Welniak LA, Ryan AE, Haas M, Murphy WJ, Via CS. CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J Immunol. 2008; 181:47–61.
   PubMed Web of Science ®Google Scholar
• De Wit D, Van Mechelen M, Zanin C, Doutrelepont JM, Velu T, Gerard C, Abramowicz D, Scheerlinck JP, De Baetselier P, Urbain J, . Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol. 1993; 150:361–366.
   PubMed Web of Science ®Google Scholar
• Tschetter JR, Mozes E, Shearer GM. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol. 2000; 165:5987–5994.
   PubMed Web of Science ®Google Scholar
• Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993; 177:1367–1381.
   PubMed Web of Science ®Google Scholar
• Crow MK, DelGiudice-Asch G, Zehetbauer JB, Lawson JL, Brot N, Weissbach H, Elkon KB. Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J Clin Invest. 1994; 94:345–352.
   PubMed Web of Science ®Google Scholar
• Puliaeva I, Puliaev R, Shustov A, Haas M, Via CS. Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses. J Immunol. 2008; 181:5912–5929.
   PubMed Web of Science ®Google Scholar
• Via CS, Shearer GM. Murine graft-versus-host disease as a model for the development of autoimmunity. Relevance of cytotoxic T lymphocytes. Ann N Y Acad Sci. 1988; 532:44–50.
   PubMed Web of Science ®Google Scholar
• Rus V, Svetic A, Nguyen P, Gause WC, Via CS. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+T cells. J Immunol. 1995; 155:2396–2406.
   PubMed Web of Science ®Google Scholar
• Puliaeva I, Puliaev R, Via CS. Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE. Autoimmun Rev. 2009; 8:219–223.
   PubMed Web of Science ®Google Scholar
• Moser M, Mizuochi T, Sharrow SO, Singer A, Shearer GM. Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+T helper cell function. J Immunol. 1987; 138:1355–1362.
   PubMed Web of Science ®Google Scholar
• Felix NJ, Allen PM. Specificity of T-cell alloreactivity. Nat Rev Immunol. 2007; 7:942–953.
   PubMed Web of Science ®Google Scholar
• Lindahl KF, Wilson DB. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J Exp Med. 1977; 145:508–522.
   PubMed Web of Science ®Google Scholar
• Singer A, Munitz TI, Golding H, Rosenberg AS, Mizuochi T. Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens. Immunol Rev. 1987; 98:143–170.
   PubMed Web of Science ®Google Scholar
• Lang TJ, Nguyen P, Papadimitriou JC, Via CS. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J Immunol. 2003; 171:5795–5801.
   PubMed Web of Science ®Google Scholar
• Via CS, Tsokos GC, Stocks NI, Clerici M, Shearer GM. Human in vitro allogeneic responses. Demonstration of three pathways of T helper cell activation. J Immunol. 1990; 144:2524–2528.
   PubMed Web of Science ®Google Scholar
• Via CS, Tsokos GC, Bermas B, Clerici M, Shearer GM. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects. J Immunol. 1993; 151:3914–3922.
   PubMed Web of Science ®Google Scholar
• Bermas BL, Petri M, Goldman D, Mittleman B, Miller MW, Stocks NI, Via CS, Shearer GM. T helper cell dysfunction in systemic lupus erythematosus [SLE]: Relation to disease activity. J Clin Immunol. 1994; 14:169–177.
   PubMed Web of Science ®Google Scholar
• Kuntz MM, Innes JB, Weksler ME. The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest. 1979; 63:151–153.
   PubMed Web of Science ®Google Scholar
• Shearer GM, Payne SM, Joseph LJ, Biddison WE. Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome. J Clin Invest. 1984; 74:496–506.
   PubMed Web of Science ®Google Scholar
• Shearer GM, Salahuddin SZ, Markham PD, Joseph LJ, Payne SM, Kriebel P, Bernstein DC, Biddison WE, Sarngadharan MG, Gallo RC. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. J Clin Invest. 1985; 76:1699–1704.
   PubMed Web of Science ®Google Scholar
• Shearer GM, Bernstein DC, Tung KS, Via CS, Redfield R, Salahuddin SZ, Gallo RC. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol. 1986; 137:2514–2521.
   PubMed Web of Science ®Google Scholar
• Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, Shearer GM. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest. 1989; 84:1892–1899.
   PubMed Web of Science ®Google Scholar
• Dolan MJ, Clerici M, Blatt SP, Hendrix CW, Melcher GP, Boswell RN, Freeman TM, Ward W, Hensley R, Shearer GM. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis. 1995; 172:79–87.
   PubMed Web of Science ®Google Scholar
• Muluk SC, Clerici M, Via CS, Weir MR, Kimmel PL, Shearer GM. Correlation of in vitro CD4+T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients. Transplantation. 1991; 52:284–291.
   PubMed Web of Science ®Google Scholar
• Schulick RD, Muluk SC, Clerici M, Bermas BL, Via CS, Weir MR, Shearer GM. Value of in vitro CD4+T helper cell function test for predicting long-term loss of human renal allografts. Transplantation. 1994; 57:480–482.
   PubMed Web of Science ®Google Scholar
• Schulick RD, Weir MB, Miller MW, Cohen DJ, Bermas BL, Shearer GM. Longitudinal study of in vitro CD4+T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation. 1993; 56:590–596.
   PubMed Web of Science ®Google Scholar
• Cohen PL, Eisenberg RA. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991; 9:243–269.
   PubMed Web of Science ®Google Scholar
• Via CS, Shearer GM. Functional heterogeneity of L3T4+T cells in MRL-lpr/lpr mice. L3T4+T cells suppress major histocompatibility complex-self-restricted L3T4+T helper cell function in association with autoimmunity. J Exp Med. 1988; 168:2165–2181.
   PubMed Web of Science ®Google Scholar
• Van Rappard-Van Der Veen FM, Radaszkiewicz T, Terraneo L, Gleichmann E. Attempts at standardization of lupus-like graft-vs-host disease: Inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J Immunol. 1983; 130:2693–2701.
   PubMed Web of Science ®Google Scholar
• Shevach EM. Macrophages and other accessory cells. In: Paul WE, editor. Fundamental immunology. New York: Raven Press; 1984. 71–107.
   Google Scholar
• Iliopoulos AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996; 25:318–336.
   PubMed Web of Science ®Google Scholar
• Crispin JC, Kyttaris V, Juang YT, Tsokos GC. Systemic lupus erythematosus: New molecular targets. Ann Rheum Dis. 2007; 66 Suppl. 3: iii65–iii69.
   PubMedGoogle Scholar